(Press-News.org) Induced pluripotent stem cells (iPSCs) taken from a patient hold great therapeutic potential for many diseases. However, studies in rodents have suggested that the body may mount an immune response and destroy cells derived from iPSCs. New research in monkeys refutes these findings, suggesting that in primates like us, such cells will not be rejected by the immune system. In the paper, publishing September 26 in the ISSCR's journal Stem Cell Reports, published by Cell Press, iPSCs from nonhuman primates successfully developed into the neurons depleted by Parkinson's disease while eliciting only a minimal immune response. The cells therefore could hold promise for successful transplantation in humans.
iPSCs are cells that have been genetically reprogrammed to an embryonic stem-cell-like state, meaning that they can differentiate into virtually any of the body's different cell types. iPSCs directed to differentiate into specific cell types offer the possibility of a renewable source of replacement cells and tissues to treat ailments, including Parkinson's disease, spinal cord injury, heart disease, diabetes, and arthritis.
Studies in rodents have suggested that iPSC-derived cells used for transplantation may be rejected by the body's immune system. To test this in an animal that is more closely related to humans, investigators in Japan directed iPSCs taken from a monkey to develop into certain neurons that are depleted in Parkinson's disease patients. When they were injected into the same monkey's brain (called an autologous transplantation), the neurons elicited only a minimal immune response. In contrast, injections of the cells into immunologically unmatched recipients (called an allogeneic transplantation) caused the body to mount a stronger immune response.
"These findings give a rationale to start autologous transplantation—at least of neural cells—in clinical situations," says senior author Dr. Jun Takahashi, of the Kyoto University's Center for iPS Cell Research and Application. The team's work also suggests that transplantation of such neurons into immunologically matched recipients may be possible with minimal use of immunosuppressive drugs.
INFORMATION:
Stem Cell Reports, Morizane et al.: "A direct comparison of autologous and allogeneic transplantation of iPSC-derived neural cells in the brain of a non-human primate."
Patient's own cells might be used as treatment for Parkinson's disease
2013-09-26
ELSE PRESS RELEASES FROM THIS DATE:
Tick tock: Marine animals with at least 2 clocks
2013-09-26
VIDEO:
This is a Eurydice crustacean swimming.
Click here for more information.
Animals living in marine environments keep to their schedules with the aid of multiple independent—and, in at least some cases, interacting—internal clocks. The findings, presented by two research groups in papers appearing in the Cell Press journals Current Biology and Cell Reports on September 26, suggest that multiple clocks—not just the familiar, 24-hour circadian clock—might even be standard ...
Newly identified antibodies effectively treat Alzheimer's-like disease in mice
2013-09-26
Alzheimer's disease is characterized by the accumulation of particular toxic proteins in the brain that are believed to underlie the cognitive decline in patients. A new study conducted in mice suggests that newly identified antibody treatments can prevent the accumulation of one of these of these toxic components, called tau proteins. The findings, online September 26 in the Cell Press journal Neuron, suggest that these antibodies may provide a basis for a promising therapy for patients with Alzheimer's disease and other neurodegenerative disorders.
In the brains of ...
Autologous transplantation shows promising results for iPS cell therapy in Parkinson's disease
2013-09-26
A research team led by Professor Jun Takahashi and Assistant Professor Asuka Morizane at the Center for iPS Cell Research and Application (CiRA) at Kyoto University, Japan, has carried out a study to compare the impact of immune response in autologous transplantation (transplantation of cells from the subject's own body) and allogeneic transplantation (transplantation of cells from a different individual of the same species). The researchers used cynomolgus monkeys to carry out transplantation into the brain of neural cells derived from iPS cells. Autologous transplantation ...
Quitting smoking easier for social media users
2013-09-26
Washington, DC (September 23, 2013) – Smoking is a major public health problem, killing approximately 443,000 people every year in the United States. Quitting smoking can have a profound effect on a person's health, but it is also one of the hardest addictions to kick. A recent paper published in the Journal of Communication found that people who engage in health specific social networking sites found it easier to quit smoking.
Joe Phua, University of Georgia, examined health-based social networking sites that focus on helping members to quit smoking. He found that as ...
A genetic map for complex diseases
2013-09-26
Although heavily studied, the specific genetic causes of "complex diseases," a category of disorders which includes autism, diabetes and heart disease, are largely unknown due to byzantine genetic and environmental interactions.
Now, scientists from the University of Chicago have created one of the most expansive analyses to date of the genetic factors at play in complex diseases—by using diseases with known genetic causes to guide them. Analyzing more than 120 million patient records and identifying trends of co-occurrence among hundreds of diseases, they created a unique ...
Bone hormone influences brain development and cognition
2013-09-26
NEW YORK, NY (September 26, 2013) — Researchers from Columbia University Medical Center (CUMC) have found that the skeleton, acting through the bone-derived hormone osteocalcin, exerts a powerful influence on prenatal brain development and cognitive functions such as learning, memory, anxiety, and depression in adult mice. Findings from the mouse study could lead to new approaches to the prevention and treatment of neurologic disorders. The study was published today in the online edition of Cell.
"The brain is commonly viewed as an organ that influences other organs ...
Study of 'sister' stem cells uncovers new cancer clue
2013-09-26
Scientists have used a brand new technique for examining individual stem cells to uncover dramatic differences in the gene expression levels – which genes are turned 'up' or 'down'– between apparently identical 'sister' pairs.
The research, published today (Thursday) in Stem Cell Reports, was conducted and funded by The Institute of Cancer Research, London. It provides the latest evidence that despite having identical DNA, sister stem cells can display considerable differences in their molecular characteristics.
The study showed that DNA methylation, a process that controls ...
Key cellular mechanism in the body's 'battery' can either spur or stop obesity
2013-09-26
Becoming obese or remaining lean can depend on the dynamics of the mitochondria, the body's energy-producing "battery," according to two new studies by Yale School of Medicine researchers featured as the cover story in the Sept. 26 issue of the journal Cell.
Mitochondria are vital cellular organelles that generate and maintain proper energy levels in complex organisms. Using animal models, the Yale research team studied mitochondria in different populations of brain cells known to be involved in the regulation of appetite. The team found that during the transition from ...
Coastal animals have their own tidal timer -- separate from the 24-hour body clock
2013-09-26
University of Leicester researchers have revealed that coastal animals have their own biological tidal timer, which is separate from their 24-hour body clock.
Experts from the University's Department of Genetics have published a paper in Current Biology which reveals the discovery of an independent clock driving coastal animals' tidal rhythms.
The paper, Dissociation of Circadian and Circatidal Timekeeping in the Marine Crustacean Eurydice pulchra, follows nearly ten years of research by Leicester geneticists, along with colleagues at the Universities of Bangor, Aberystwyth ...
Stem cell scientists identify key regulator controlling formation of blood-forming stem cells
2013-09-26
(TORONTO, Canada – Sept. 26, 2013) – Stem cell scientists have moved one step closer to producing blood-forming stem cells in a Petri dish by identifying a key regulator controlling their formation in the early embryo, shows research published online today in Cell.
The work was reported by Dr. Gordon Keller, Director of the McEwen Centre for Regenerative Medicine, and Senior Scientist at Princess Margaret Cancer Centre, both at University Health Network. Dr. Keller is also Professor in the Department of Medical Biophysics at the University of Toronto and holds a Canada ...